CCHR: Antidepressants—Addiction and Withdrawal
|Date:||Apr 23 2015|
|Category:||Big Pharma, Pharmaceutical, Psych Drugs|
All antidepressant Warnings/Studies click here http://www.cchrint.org/psychiatric-dr…
Karen Barth Menzies, speaking about Paxil/antidepressant addiction and withdrawal. Menzies has been on the forefront of the SSRI antidepressant litigation for more than a decade against defendants such as, GlaxoSmithKline, Pfizer and Eli Lilly in cases involving antidepressant-induced suicide, withdrawal and birth defects. In 2003, she was appointed Lead Counsel for the Plaintiffs’ Steering Committee in the Paxil Products Liability Litigation.. She was appointed co-liaison counsel in the Paxil birth defect case in Philadelphia, Pennsylvania. Karen has testified twice before FDA advisory boards as well as the California State Legislature on the safety concerns regarding the SSRI antidepressants and the manufacturers’ misconduct.
For studies and warnings on antidepressants (including addiction and withdrawal) visit
Leave a reply
Your email address will not be published. Fields marked * are mandatory.